CVE-2020-4082 Cross-site scripting in "HCL Connections"
Remote attackers can execute scripts in victims' browsers via crafted URLs to steal authentication credentials in HCL Connections.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Over the internet
- Victim action needed
- A user has to click or open something
- Fix
- None listed
What is CVE-2020-4082?
CVE-2020-4082 is a medium-severity cross-site scripting vulnerability in "HCL Connections", published on 5 Mar 2020. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.
Official description
The HCL Connections 5.5 help system is vulnerable to cross-site scripting, caused by improper validation of user-supplied input. A remote attacker could exploit this vulnerability using a specially-crafted URL to execute script in a victim's Web browser within the security context of the hosting Web site, once the URL is clicked. An attacker could use this vulnerability to steal the victim's cookie-based authentication credentials.
Weakness: CWE-79
Which versions are affected by CVE-2020-4082?
It affects 1 product.
Products include Hcltech Connections.
How do I fix CVE-2020-4082?
No fix has been published for CVE-2020-4082 yet. Limit exposure of the affected software until one is available.
Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.
Is CVE-2020-4082 being exploited?
There is no known exploitation of CVE-2020-4082 in the wild and no public exploit code.
Other vulnerabilities in "HCL Connections"
- CVE-2020-4085 Information disclosure in "HCL Connections"
- CVE-2019-4209 Open redirect in HCL Connections
- CVE-2023-28018 HCL Connections s vulnerable to possible denial of service for certain users
- CVE-2020-4083 Information disclosure in "HCL Connections"
- CVE-2026-21788 HCL Connections is vulnerable to cross-site scripting (XSS)
Sources
Also known as GHSA-5wg4-rfc2-hgh3.